Literature DB >> 14554080

Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells.

Marc S Horwitz1, Alex Ilic, Cody Fine, Enrique Rodriguez, Nora Sarvetnick.   

Abstract

The induction of autoimmunity by viruses has been hypothesized to occur by a number of mechanisms. Coxsackievirus B4 (CB4) induces hyperglycemia in SJL mice resembling diabetes in humans. While virus is effectively cleared within 2 weeks, hyperglycemia does not appear until about 8-12 weeks postinfection at a time when replicative virus is no longer detectable. In SJL mice, reinfection with CB4 enhanced the development of hyperglycemia. As predicted, the immune system responded more rapidly to the second infection and virus was cleared more swiftly. However, while infiltrating T cells were found within the pancreas, depletion of the CD4 T cell population prior to secondary infection or use of CD8 knock-out mice had no effect on the development of virus-mediated hyperglycemia. In conclusion, enhanced hyperglycemia induced by CB4 occurs independent of the T cell response.

Entities:  

Mesh:

Year:  2003        PMID: 14554080     DOI: 10.1016/s0042-6822(03)00462-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.

Authors:  Firas Elmastour; Hela Jaïdane; Mehdi Benkahla; Leila Aguech-Oueslati; Famara Sane; Aymen Halouani; Ilka Engelmann; Antoine Bertin; Moncef Mokni; Jawhar Gharbi; Mahjoub Aouni; Enagnon K Alidjinou; Didier Hober
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

2.  A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Charlotta Polacek; Jana Precechtelova; Miriam Badurova; Martin Sojka; Camilla Mohlin; Stina Israelsson; Kjell Johansson; Shubhada Bopegamage; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

3.  Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system.

Authors:  Firas Elmastour; Hela Jaidane; Leila Aguech-Oueslati; Mehdi Ayech Benkahla; Mahjoub Aouni; Jawhar Gharbi; Famara Sane; Didier Hober
Journal:  Virulence       Date:  2016-03-30       Impact factor: 5.882

4.  Enterovirus infections: Pivoting role of the adaptive immune response.

Authors:  Shubhada Bopegamage
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

5.  Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome?

Authors:  Nora M Chapman
Journal:  Virulence       Date:  2016-12-09       Impact factor: 5.882

6.  Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.

Authors:  Mehdi A Benkahla; Famara Sane; Antoine Bertin; Anais-Camille Vreulx; Firas Elmastour; Hela Jaidane; Rachel Desailloud; Didier Hober
Journal:  Sci Rep       Date:  2019-07-12       Impact factor: 4.379

Review 7.  Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies.

Authors:  Matthias von Herrath
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.